Latest Updates on ARTL
Latest Trading on NASDAQ
|52 Week Range||
|Avg. Volume (Weekly)||123.95K|
No data to display.
Artelo Biosciences Inc. is a biopharmaceutical company. It is engaged in development and commercialization of proprietary therapeutics targeting the endocannabinoid system. The company’s product pipeline consists of ART27.13, ART12.11 and ART26.12 which are in clinical stage. Artelo Biosciences Inc. is based in La Jolla, CA.